POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS

Clinical trials for POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS explained in plain language.

Never miss a new study

Get alerted when new POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS trials appear

Sign up with your email to follow new studies for POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New bone drug goes Head-to-Head with market leader

Disease control Completed

This study tested whether a new osteoporosis drug called Bmab 1000 works as well as the established medication Prolia. Researchers enrolled 479 postmenopausal women with osteoporosis and randomly assigned them to receive either the new drug or Prolia via injection every six month…

Matched conditions: POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS

Phase: PHASE3 • Sponsor: Biocon Biologics UK Ltd • Aim: Disease control

Last updated Mar 31, 2026 12:11 UTC

POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS

Get alerted when new POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS trials appear

New bone drug goes Head-to-Head with market leader